Jonathan Adams's most recent trade in BioVie Inc was a trade of 1,000 Common Stock done . Disclosure was reported to the exchange on Feb. 2, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
BioVie Inc | Jonathan Adams | EVP Liver Cirrhosis Programs | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Feb 2022 | 1,000 | 48,630 (0%) | 0% | 0 | Common Stock | |
BioVie Inc | Jonathan Adams | EVP Liver Cirrhosis Programs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2021 | 124,167 | 124,167 | - | - | Stock Option (right to buy) | |
BioVie Inc | Jonathan Adams | EVP Liver Cirrhosis Programs | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Jun 2021 | 10,000 | 49,630 (0%) | 0% | 0 | Common Stock | |
BioVie Inc | Jonathan Adams | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 800 | 33,364 | - | - | options |